| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dietrich Mack | |
| Enno Stürenburg | |||
| P2860 | cites work | Plasmid-determined AmpC-type beta-lactamases | Q24535748 |
| Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 | ||
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| A functional classification scheme for beta-lactamases and its correlation with molecular structure | Q24677460 | ||
| Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin linked to carbapenem resistance | Q30165422 | ||
| MYSTIC program: summary of European data from 1997 to 2000. | Q30668895 | ||
| Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. | Q33666596 | ||
| Antimicrobial resistance in intensive care units | Q33673770 | ||
| Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. | Q33690464 | ||
| A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae | Q33690561 | ||
| Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme | Q33692603 | ||
| CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia | Q33694795 | ||
| Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. | Q33702840 | ||
| OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates | Q33702898 | ||
| Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. | Q33963824 | ||
| Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut | Q33964309 | ||
| In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group | Q40778902 | ||
| Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics | Q41311524 | ||
| Acquired carbapenemases | Q41530522 | ||
| Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams | Q41676898 | ||
| OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginosa | Q42662430 | ||
| A standard numbering scheme for the class A beta-lactamases | Q42861944 | ||
| CTX-m-3 beta-lactamase-producing Escherichia coli from Greece | Q43469396 | ||
| Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998). | Q43542320 | ||
| Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia | Q43575980 | ||
| Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region | Q43587147 | ||
| Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model. | Q43635369 | ||
| Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey | Q43665705 | ||
| Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. | Q43785356 | ||
| Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases | Q43817881 | ||
| Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime | Q43820678 | ||
| Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests | Q43869460 | ||
| Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. | Q43873529 | ||
| Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). | Q43945108 | ||
| Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals | Q43991111 | ||
| Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France. | Q44016374 | ||
| Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes | Q44142354 | ||
| Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study | Q44192829 | ||
| Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection | Q44224736 | ||
| Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China | Q44233614 | ||
| Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). | Q44235758 | ||
| Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers | Q44256800 | ||
| Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns | Q44256802 | ||
| Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000). | Q44256808 | ||
| Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. | Q44258661 | ||
| Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates | Q44268011 | ||
| Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli | Q44358172 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes | Q44436393 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea | Q33973766 | ||
| Diversification of Escherichia coli expressing an SHV-type extended-spectrum beta-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. | Q33976117 | ||
| Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene | Q33976426 | ||
| Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin | Q33976690 | ||
| Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. | Q33976916 | ||
| Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae | Q33977146 | ||
| Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae | Q33978938 | ||
| Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan | Q33979601 | ||
| A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae | Q33979670 | ||
| A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil | Q33980082 | ||
| OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene | Q33981359 | ||
| In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain | Q33981993 | ||
| Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya | Q33982586 | ||
| Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly | Q33982717 | ||
| CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop | Q33983530 | ||
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Evolution of TEM-related extended-spectrum beta-lactamases in Korea | Q33983781 | ||
| Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes | Q33995218 | ||
| Treatment options for extended-spectrum beta-lactamase-producers | Q34061898 | ||
| Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland | Q34104447 | ||
| Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs | Q34104453 | ||
| First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan | Q34105979 | ||
| Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
| CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli | Q34108823 | ||
| Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types | Q34112598 | ||
| Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). | Q34135508 | ||
| New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy | Q34192597 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam | Q34251851 | ||
| Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain | Q34438380 | ||
| Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms | Q34459151 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. | Q34652460 | ||
| Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China | Q39652923 | ||
| Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases | Q39671119 | ||
| OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa | Q39780297 | ||
| Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant. | Q39783976 | ||
| OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. | Q39785056 | ||
| Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors | Q39817435 | ||
| Evolution of plasmid-coded resistance to broad-spectrum cephalosporins | Q39850194 | ||
| Kinetic interactions of tazobactam with beta-lactamases from all major structural classes | Q39865634 | ||
| Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences | Q39866689 | ||
| Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase | Q39881861 | ||
| Beta-lactamases | Q40080810 | ||
| Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model | Q40284385 | ||
| Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia | Q40625910 | ||
| In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group | Q40778897 | ||
| Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center | Q44685672 | ||
| Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. | Q45005051 | ||
| Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity | Q46500735 | ||
| Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa | Q48038272 | ||
| Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases | Q48300874 | ||
| CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes | Q50121978 | ||
| Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. | Q52864073 | ||
| Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. | Q53632367 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. | Q54034069 | ||
| Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. | Q54042026 | ||
| Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. | Q54049533 | ||
| Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. | Q54058575 | ||
| Cefotaxime-hydrolysing beta lactamases in Morganella morganii. | Q54070341 | ||
| In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus. | Q54070929 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Bases of variation in resistance to beta-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase. | Q54151855 | ||
| A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. | Q54316090 | ||
| Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases. | Q54331490 | ||
| Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins. | Q54335716 | ||
| In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. | Q54354740 | ||
| Klebsiella pneumoniae strains more resistant to ceftazidime than to other third-generation cephalosporins. | Q54399627 | ||
| Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. | Q54401131 | ||
| A hospital outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance | Q56896786 | ||
| Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit | Q59245539 | ||
| Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong KongNote | Q59699570 | ||
| Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit | Q71114922 | ||
| Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital | Q73250455 | ||
| Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals | Q73332067 | ||
| Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases | Q73366783 | ||
| Emergence of a carbapenem-resistant Klebsiella pneumoniae | Q73699548 | ||
| Detection of extended-spectrum beta-lactamases with Etest and double-disc potentiation methods | Q74138077 | ||
| Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group | Q74509254 | ||
| Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? | Q74802303 | ||
| Do we need fourth-generation cephalosporins? | Q77703190 | ||
| Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups | Q77805594 | ||
| Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection | Q77972984 | ||
| Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia | Q78408808 | ||
| CTX-M extended-spectrum beta-lactamase arrives in the UK | Q78871915 | ||
| Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens | Q34708485 | ||
| Plasmid-borne AmpC beta-lactamases | Q34776284 | ||
| Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China | Q34821049 | ||
| Pseudomonas aeruginosa: resistance and therapy | Q34845149 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome | Q35007119 | ||
| SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients | Q35113486 | ||
| Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure | Q35120519 | ||
| In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. | Q35122321 | ||
| Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. | Q35133558 | ||
| OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain | Q35134964 | ||
| Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae | Q35136019 | ||
| Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase | Q35252077 | ||
| Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases | Q35254248 | ||
| Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase | Q35280038 | ||
| Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility | Q35281765 | ||
| Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms | Q35814714 | ||
| In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae | Q35822646 | ||
| Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant | Q35896975 | ||
| Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. | Q36527781 | ||
| Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find | Q36546913 | ||
| OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa | Q36753213 | ||
| Comparison of the sequences of class A beta-lactamases and of the secondary structure elements of penicillin-recognizing proteins | Q36756963 | ||
| Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. | Q37071142 | ||
| Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases | Q37073128 | ||
| More extended-spectrum beta-lactamases | Q37520309 | ||
| Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins | Q39399105 | ||
| Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain | Q39476379 | ||
| Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes | Q39590687 | ||
| Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland | Q39614205 | ||
| Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. | Q39626854 | ||
| Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). | Q39651162 | ||
| CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France | Q39651232 | ||
| Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa | Q39651346 | ||
| Novel complex sul1-type integron in Escherichia coli carrying bla(CTX-M-9). | Q39652578 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 273-295 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Infection | Q6295344 |
| P1476 | title | Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control | |
| Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control | |||
| P478 | volume | 47 |
| Q30986331 | A qPCR and multiplex pyrosequencing assay combined with automated data processing for rapid and unambiguous detection of ESBL-producers Enterobacteriaceae |
| Q34398603 | A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. |
| Q42009069 | AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India |
| Q28242374 | Ampicillin/sulbactam: current status in severe bacterial infections |
| Q35765446 | Antibiotic combination as empirical therapy for extended spectrum Beta-lactamase. |
| Q51853757 | Antimicrobial resistance and pathogenicity of Escherichia coli isolated from common dairy products in the Lebanon. |
| Q42408631 | Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum beta-lactamase genes |
| Q36523688 | Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens |
| Q40834519 | Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance |
| Q37053548 | CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals. |
| Q50979239 | Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia. |
| Q46758181 | Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital |
| Q44822561 | Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster |
| Q46840109 | Comprehensive analysis of ß-lactam antibiotics including penicillins, cephalosporins, and carbapenems in poultry muscle using liquid chromatography coupled to tandem mass spectrometry |
| Q46643996 | Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. |
| Q33235526 | Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q53887379 | Detection of extended-spectrum beta-lactamases produced by Chilean isolates of Klebsiella pneumoniae by two synergy methods. |
| Q36482863 | E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates |
| Q36804075 | Effect of subtherapeutic administration of antibiotics on the prevalence of antibiotic-resistant Escherichia coli bacteria in feedlot cattle |
| Q42912527 | Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae |
| Q35084748 | Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures |
| Q38475591 | Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates |
| Q33736461 | Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin |
| Q36529315 | Extended spectrum beta lactamase peritonitis: Time for innovation? |
| Q24812037 | Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania |
| Q34574557 | Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004. |
| Q36363226 | In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections |
| Q37072068 | In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor |
| Q42075488 | In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals |
| Q40522059 | Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon |
| Q41010233 | Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype. |
| Q91912473 | Isolation Precautions in the Inpatient Setting |
| Q40230467 | Molecular epidemiology of quinolon resistant strains of extended spectrum beta-lactamase producing Escherichia coli |
| Q41912793 | Multi-Locus Sequence Typing (MLST) and Repetitive Extragenic Palindromic Polymerase Chain Reaction (REP-PCR), characterization of shigella spp. over two decades in Tianjin China. |
| Q81761055 | Occurrence and regional distribution of SHV-type extended-spectrum beta-lactamases in Hungary |
| Q35533202 | Pathogenic and commensal Escherichia coli from irrigation water show potential in transmission of extended spectrum and AmpC β-lactamases determinants to isolates from lettuce |
| Q40222930 | Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases |
| Q40082536 | Preliminary insights into the occurrence of similar clones of extended-spectrum beta-lactamase-producing bacteria in humans, animals and the environment in Tanzania: A systematic review and meta-analysis between 2005 and 2016. |
| Q55365818 | Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia. |
| Q36857383 | Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital |
| Q41429594 | Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates |
| Q42577909 | Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran |
| Q33883791 | Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases |
| Q40934504 | Pulmonary Pneumatocele in a Pneumonia Patient Infected with Extended-Spectrum β-Lactamase Producing Proteus mirabilis |
| Q40324905 | Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications |
| Q37405325 | Risk Factors for and Outcomes Associated with Clinical Isolates ofEscherichia coliandKlebsiellaSpecies Resistant to Extended-Spectrum Cephalosporins among Patients Admitted to Canadian Hospitals |
| Q37763019 | Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review |
| Q51110514 | Susceptibility to disinfectants in antimicrobial-resistant and -susceptible isolates of Escherichia coli, Enterococcus faecalis and Enterococcus faecium from poultry-ESBL/AmpC-phenotype of E. coli is not associated with resistance to a quaternary am |
| Q41451515 | TEM and SHV Genes in Klebsiella pneumoniae Isolated from Cockroaches and Their Antimicrobial Resistance Pattern |
| Q41807595 | Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey |
| Q38473574 | Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands. |
| Q42537177 | Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology |
| Q82357027 | [Treatment of infections by wide spectrum betalactamase-producing microorganisms: a new therapeutic challenge] |
Search more.